87R5114 SRA-D
By: Buckingham S.B. No. 2009
A BILL TO BE ENTITLED
AN ACT
relating to the designation of centers of excellence for the
management and treatment of placenta accreta spectrum disorder.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Chapter 32, Health and Safety Code, is amended by
adding Subchapter G to read as follows:
SUBCHAPTER G. CENTERS OF EXCELLENCE FOR MANAGEMENT AND TREATMENT
OF PLACENTA ACCRETA SPECTRUM DISORDER
Sec. 32.201. DEFINITION. In this subchapter, "placenta
accreta spectrum disorder" includes placenta accreta, placenta
increta, and placenta percreta.
Sec. 32.202. DESIGNATION OF CENTERS OF EXCELLENCE. (a) The
department, in consultation with the Texas Maternal Mortality and
Morbidity Review Committee established under Chapter 34, shall
designate as centers of excellence for the management and treatment
of placenta accreta spectrum disorder one or more health care
entities or programs in this state, including any institution or
community hospital with the appropriate resources and personnel, as
determined by the department and the review committee.
(b) The executive commissioner, in consultation with the
department and the Texas Maternal Mortality and Morbidity Review
Committee, shall adopt rules necessary for a health care entity or
program in this state to be designated as a center of excellence for
management and treatment of placenta accreta spectrum disorder.
Sec. 32.203. SUBCOMMITTEE. (a) The department, in
consultation with the Texas Maternal Mortality and Morbidity Review
Committee, shall appoint a subcommittee of the review committee to
advise the executive commissioner on the adoption of rules under
Section 32.202. As part of the subcommittee's duties under this
subsection, the subcommittee specifically shall advise the
executive commissioner on the criteria necessary for a health care
entity or program in this state to be awarded a designation under
this subchapter.
(b) The subcommittee must consist of individuals with
expertise in the management and treatment of placenta accreta
spectrum disorder. A majority of the members of the subcommittee
must practice in those areas in a health profession in this state.
The subcommittee may include national and international experts.
Sec. 32.204. PRIORITY CONSIDERATIONS FOR CENTER
DESIGNATIONS. The rules adopted under Section 32.202 must
prioritize awarding a designation under this subchapter to a health
care entity or program that:
(1) offers specialized management services for
placenta accreta spectrum disorder through a multi-specialty
clinical program and an associated hospital that provides advanced
neonatal and maternal care in accordance with the hospital's level
of care designation assigned under Section 241.182;
(2) demonstrates a significant commitment to research
in and advancing the field of care for placenta accreta spectrum
disorder;
(3) fosters telemedicine, referral, and transport
relationships with rural hospitals in this state; and
(4) integrates an advanced placenta accreta spectrum
disorder management program with a program that provides
appropriate long-term monitoring and follow-up care for patients.
Sec. 32.205. REQUIREMENTS FOR CENTER DESIGNATION. The
rules adopted under Section 32.202 must ensure that a health care
entity or program in this state that receives a center of excellence
designation under this subchapter:
(1) provides or is affiliated with a hospital that
provides advanced neonatal and maternal care in accordance with the
hospital's level of care designation assigned under Section
241.182;
(2) establishes minimum criteria for medical,
nursing, ancillary, and support staff, in addition to any other
criteria required under Section 32.202;
(3) measures short-term and long-term patient
diagnostic and therapeutic outcomes; and
(4) submits to the department annual reports
containing aggregate data on short-term and long-term diagnostic
and therapeutic outcomes as requested or required by the department
and makes those reports available to the public on the entity's or
program's Internet website.
SECTION 2. (a) Not later than December 1, 2021, the
Department of State Health Services, in consultation with the Texas
Maternal Mortality and Morbidity Review Committee established
under Chapter 34, Health and Safety Code, shall appoint members to
the subcommittee as required by Section 32.203, Health and Safety
Code, as added by this Act.
(b) Not later than September 1, 2022, the executive
commissioner of the Health and Human Services Commission shall
adopt rules as required by Section 32.202, Health and Safety Code,
as added by this Act.
(c) Not later than September 1, 2022, the Department of
State Health Services shall begin awarding designations of centers
of excellence as required by Subchapter G, Chapter 32, Health and
Safety Code, as added by this Act.
SECTION 3. This Act takes effect September 1, 2021.